🚀 VC round data is live in beta, check it out!
Chabiotech Valuation Multiples
Discover revenue and EBITDA valuation multiples for Chabiotech and similar public comparables like OPKO Health, SELLAS Life Sciences, Hyundai Bioscience, Sana Biotechnology and more.
Chabiotech Overview
About Chabiotech
Chabiotech Co Ltd is engaged in the manufacturing of biological products.
Founded
2002
HQ
Employees
N/A
Website
Sectors
Financials (FY)
EV
$1B
Chabiotech Financials
Chabiotech reported last fiscal year revenue of $858M and negative EBITDA of ($22M).
In the same fiscal year, Chabiotech generated $246M in gross profit, ($22M) in EBITDA losses, and had net loss of ($74M).
Chabiotech P&L
In the most recent fiscal year, Chabiotech reported revenue of $858M and EBITDA of ($22M).
Chabiotech expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $858M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $246M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 29% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($22M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (3%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (4%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($74M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (9%) | XXX | XXX | XXX |
| Net Debt | — | — | $393M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Chabiotech Stock Performance
Chabiotech has current market cap of $941M, and enterprise value of $1B.
Market Cap Evolution
Chabiotech's stock price is $12.31.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $941M | 0.4% | XXX | XXX | XXX | $-0.97 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialChabiotech Valuation Multiples
Chabiotech trades at 1.5x EV/Revenue multiple, and (60.9x) EV/EBITDA.
Chabiotech Financial Valuation Multiples
As of April 18, 2026, Chabiotech has market cap of $941M and EV of $1B.
Equity research analysts estimate Chabiotech's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Chabiotech has a P/E ratio of (12.7x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $941M | XXX | $941M | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 1.5x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (60.9x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (40.4x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 5.4x | XXX | XXX | XXX |
| P/E | — | XXX | (12.7x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (8.7x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Chabiotech Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Chabiotech Margins & Growth Rates
Chabiotech's revenue in the last fiscal year grew by 21%.
Chabiotech Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 21% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (3%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (142%) | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 6% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 8% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 33% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Chabiotech Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Chabiotech | XXX | XXX | XXX | XXX | XXX | XXX |
| OPKO Health | XXX | XXX | XXX | XXX | XXX | XXX |
| SELLAS Life Sciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Hyundai Bioscience | XXX | XXX | XXX | XXX | XXX | XXX |
| Sana Biotechnology | XXX | XXX | XXX | XXX | XXX | XXX |
| MeiraGTx | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Chabiotech M&A Activity
Chabiotech acquired XXX companies to date.
Last acquisition by Chabiotech was on XXXXXXXX, XXXXX. Chabiotech acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Chabiotech
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialChabiotech Investment Activity
Chabiotech invested in XXX companies to date.
Chabiotech made its latest investment on XXXXXXXX, XXXXX. Chabiotech invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Chabiotech
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Chabiotech
| When was Chabiotech founded? | Chabiotech was founded in 2002. |
| Where is Chabiotech headquartered? | Chabiotech is headquartered in South Korea. |
| Who is the CEO of Chabiotech? | Chabiotech's CEO is Sang-Hoon Oh. |
| Is Chabiotech publicly listed? | Yes, Chabiotech is a public company listed on Korea Exchange. |
| What is the stock symbol of Chabiotech? | Chabiotech trades under 085660 ticker. |
| When did Chabiotech go public? | Chabiotech went public in 2005. |
| Who are competitors of Chabiotech? | Chabiotech main competitors are OPKO Health, SELLAS Life Sciences, Hyundai Bioscience, Sana Biotechnology. |
| What is the current market cap of Chabiotech? | Chabiotech's current market cap is $941M. |
| What is the current revenue of Chabiotech? | Chabiotech's last fiscal year revenue is $858M. |
| What is the current EV/Revenue multiple of Chabiotech? | Current revenue multiple of Chabiotech is 1.5x. |
| Is Chabiotech profitable? | No, Chabiotech is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.